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Objectives We examined the potential influence of both sample selection effects and Hawthorne effects in
the behavioural HIV Prevention Trial Network 068 study, designed to examine whether cash transfers
conditional on school attendance reduce HIV acquisition in young South African women. We explored
whether school enrolment among study participants differed from the underlying population, and whether
differences existed at baseline (sample selection effect) or arose during study participation (Hawthorne
effect). Methods We constructed a cohort of 3889 young women aged 11-20 years using data from the
Agincourt Health and socio-Demographic Surveillance System. We compared school enrolment in 2011 (trial
start) and 2015 (trial end) between those who did (n=1720) and did not (n=2169) enrol in the trial. To
isolate the Hawthorne effect, we restricted the cohort to those enrolled in school in 2011. Results In 2011,
trial participants were already more likely to be enrolled in school (99%) compared with non-participants
(93%). However, this association was attenuated with covariate adjustment (adjusted risk difference (aRD)
(95% CI): 2.9 (− 0.7 to 6.5)). Restricting to those enrolled in school in 2011, trial participants were also more
likely to be enrolled in school in 2015 (aRD (95% CI): 4.9 (1.5 to 8.3)). The strength of associations
increased with age. Conclusions Trial participants across both study arms were more likely to be enrolled in
school than non-participants. Our findings suggest that both sample selection and Hawthorne effects may
have diminished the differences in school enrolment between study arms, a plausible explanation for the null
trial findings. The Hawthorne-specific findings generate hypotheses for how to structure school retention
interventions to prevent HIV.
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AbstrACt
Objectives We examined the potential influence of 
both sample selection effects and Hawthorne effects in 
the behavioural HIV Prevention Trial Network 068 study, 
designed to examine whether cash transfers conditional 
on school attendance reduce HIV acquisition in young 
South African women. We explored whether school 
enrolment among study participants differed from the 
underlying population, and whether differences existed at 
baseline (sample selection effect) or arose during study 
participation (Hawthorne effect).
Methods We constructed a cohort of 3889 young 
women aged 11–20 years using data from the Agincourt 
Health and socio-Demographic Surveillance System. We 
compared school enrolment in 2011 (trial start) and 2015 
(trial end) between those who did (n=1720) and did not 
(n=2169) enrol in the trial. To isolate the Hawthorne effect, 
we restricted the cohort to those enrolled in school in 
2011.
results In 2011, trial participants were already more 
likely to be enrolled in school (99%) compared with 
non-participants (93%). However, this association was 
attenuated with covariate adjustment (adjusted risk 
difference (aRD) (95% CI): 2.9 (− 0.7 to 6.5)). Restricting 
to those enrolled in school in 2011, trial participants were 
also more likely to be enrolled in school in 2015 (aRD 
(95% CI): 4.9 (1.5 to 8.3)). The strength of associations 
increased with age.
Conclusions Trial participants across both study arms 
were more likely to be enrolled in school than non-
participants. Our findings suggest that both sample 
selection and Hawthorne effects may have diminished 
the differences in school enrolment between study arms, 
a plausible explanation for the null trial findings. The 
Hawthorne-specific findings generate hypotheses for how 
to structure school retention interventions to prevent HIV.
IntrOduCtIOn 
The evidence base for public health inter-
ventions largely comes from rigorous epide-
miological studies.1 2 However, results from 
epidemiological studies may not be gener-
alisable (or ‘externally valid’) when study 
participant characteristics differ from those 
in the target population, even with rando-
misation of exposure (referred to here as 
‘sample selection effect’).3 Further threats to 
validity can occur if study participation itself 
induces behaviour change (Hawthorne effect, 
research participation effect or trial effect, 
referred to here, collectively, as ‘Hawthorne 
effect’).4 5 Analysing study data to examine 
how results may have differed in the target 
population to which we would like to make 
inference is critical to making valid conclu-
sions and policy recommendations.
Although epidemiological training and 
research have long included at least cursory 
examinations of external validity,6 with more 
recent methodological advancements around 
transportability of effect estimates from study 
strengths and limitations of this study
 ► To our knowledge, this study is the first to empirically 
examine whether Hawthorne effects may have 
influenced study results in an HIV prevention trial.
 ► We analysed longitudinal data on a key study 
outcome (school enrolment) for the underlying 
population from which study participants were 
drawn. Complete data are not typically available for 
source populations in research studies.
 ► Our Hawthorne-specific findings suggest that 
aspects of the HIV Prevention Trial Network (HPTN) 
068 protocol could potentially be adapted for school 
retention interventions to prevent HIV.
 ► It is important to note that data on HIV incidence, the 
primary endpoint of HPTN 068, were not available 
for the underlying target population.
 ► The differences we attribute to the Hawthorne 
effect were estimated in an observational data set 
with adjustment for key sociodemographic 
characteristics. The potential for uncontrolled 
confounding requires that our results be interpreted 
cautiously.
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populations to target populations,7–9 empirical evaluation 
of Hawthorne effects is rare. The limited evidence for 
Hawthorne effects comes largely from clinical randomised 
controlled trials, most often assessed in cancer and nutri-
tion studies,10 11 with supporting evidence from HIV 
treatment research.12 Trials designed to affect behaviour 
change may be particularly susceptible to Hawthorne 
effects as the behaviours in question may be influenced 
by trial participation.13 14 This is particularly true in HIV 
prevention research, where Hawthorne effects could pose 
validity threats if unexpectedly low HIV incidence occurs 
due to trial-induced risk behaviour changes.15 To our 
knowledge, no prior HIV prevention trial has empirically 
examined whether Hawthorne effects influenced study 
results.
In this study, we examine the potential influence of 
both sample selection effects and Hawthorne effects in 
the behavioural HIV Prevention Trial Network (HPTN) 
068 study,16 17 designed to examine whether cash transfers 
conditional on school attendance reduce HIV acquisition 
in young South African women. Contrary to the study 
hypothesis, no difference in HIV acquisition was observed 
between study arms, with high levels of school enrolment 
and low HIV incidence in both arms. These findings were 
surprising given the high background rates of school 
dropout in the study area18–20 and the large body of 
evidence showing the positive impact of cash transfers on 
schooling outcomes,21 and limited the ability to explore 
schooling as a mechanism to reduce HIV risk.
Here, we contextualise HPTN 068 findings, using data 
on school enrolment in the underlying target population 
routinely collected by the Agincourt Health and socio-De-
mographic Surveillance System (HDSS) in which HPTN 
068 was nested. We examine whether school enrolment 
trajectories of trial participants differed from non-par-
ticipants, and whether differences could be attributed 
to existing differences in school enrolment at baseline 
(sample selection effect) or differences that arose during 
study participation (Hawthorne effect).
MethOds
study setting and population
The Agincourt HDSS is located in the rural Bushbuck-
ridge municipality of the Mpumalanga province, South 
Africa,22 and has routinely collected annual vital event 
data on all people living in the study area since 1992. 
Other sociodemographic data are collected at regular 
but less frequent intervals. For example, educational 
attainment is queried every 3 years, employment data 
are collected every 4 years, and a household asset index 
is measured every other year. Community, household 
and individual consents have been obtained for all Agin-
court HDSS census research since its inception, with 
informed verbal consent obtained at each census round. 
The Agincourt HDSS currently surveys the full cohort of 
over 115 000 people living across 31 villages, in an area 
of economic disadvantage with historically low access to 
public services. However, government schools in the study 
site are free and often provide feeding programmes. HIV 
contributes a large burden to the community, with 19% 
HIV prevalence overall in those aged 15 years and older.23
HPTN 068 was a phase III individually randomised 
trial designed to examine whether cash transfers condi-
tional on school attendance influence the risk of HIV 
acquisition in young women.16 17 Young women and their 
caregivers were randomly assigned to receive a monthly 
cash transfer conditional on ≥80% school attendance or 
no cash transfer. The size of the monthly cash transfer 
was 300 rands (R; about US$30 in 2012), and was divided 
into R200 provided to the caregiver and R100 provided 
to the young woman. Key selection criteria for participa-
tion in the study were current enrolment in grades 8–11; 
age 13–20 years; not married or pregnant at baseline; and 
having a caregiver with the documents necessary to open 
a bank account. Age-eligible young women were identi-
fied from Agincourt HDSS records to be contacted for 
further eligibility screening (n=10 134).16 Between March 
2011 and December 2012, a total of 2533 young women 
were enrolled. Participants were seen annually for a 
maximum of 3 years from enrolment or until high school 
graduation. Thus, participants who enrolled in the trial in 
2011 in grade 11 could exit the study as early as 2012 after 
graduating high school. Participants who enrolled in the 
trial in 2012 in grade 8 or 9 could exit the study as late as 
March 2015 (figure 1).
Cohort construction
We constructed our analytical cohort to identify all young 
women living in the study area at the time of trial start 
(2011) regardless of trial participation status. Further 
restrictions were applied to build a cohort of young 
women on comparable age/grade trajectories and to 
match key HPTN 068 selection criteria. First, we restricted 
Figure 1 Timeline of Agincourt HDSS education data collection and HPTN 068 trial duration. HDSS, Health and socio-
Demographic Surveillance System; HPTN, HIV Prevention Trial Network.  
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the cohort to include young women between the ages of 
13 and 20 years in 2011 or 2012. Based on education data 
collected by the Agincourt HDSS in 2009 (education data 
were collected in 2009 but not again until 2012), we also 
restricted the cohort to those who were enrolled in grades 
that projected to grades 8–11 in 2011 or 2012, assuming a 
one-grade increase each year.
Key measures
Our primary exposure of interest was HPTN 068 trial 
participation (both trial arms combined). We analysed both 
arms together because trial results indicated essentially 
no differences in school attendance and enrolment data 
between the arms. School attendance was high (≥80%) 
for 95% of the intervention arm and 96% of the control 
arm participants. Permanent school dropout occurred at 
a rate of 3 per 100 person years in both arms.17
Our primary outcome of interest was school enrolment, 
which we calculated at 2011 and 2015 based on Agin-
court HDSS education data collected in 2009, 2012 and 
2015. We used the 2011 school enrolment outcome 
to assess whether enrolment patterns were already 
different at the beginning of the trial, indicating a 
potential sample selection effect. We used the 2015 
school enrolment outcome to assess whether enrolment 
patterns were different at the end of the trial, when 
both sample selection and Hawthorne effects could be 
present. We considered young women as enrolled in 
school if they indicated current school enrolment or if 
they reported a grade 12 attainment, the final year of 
secondary schooling.
With the 2009, 2012 and 2015 education modules, 
fieldworkers updated the highest education level each 
young woman achieved and recorded whether or not she 
was currently enrolled in school. The 2015 time-point 
aligned with a census education module, so enrolment 
status decisions were made based on data reported at that 
time. The 2011 time-point did not align with a census 
education module, so we inferred enrolment status at 
this time-point based on changes in status between 2009 
and 2012. If young women reported enrolment in both 
2009 and 2012, we inferred they were also enrolled in 
2011. If young women reported enrolment in 2009 but 
not 2012, we used changes in educational attainment 
to infer whether school dropout had occurred before 
or after 2011. For example, if a young woman reported 
grade 7 attainment in 2009 and grade 10 attainment in 
2012, we assumed that the 3 years of additional education 
were accumulated in 2009, 2010 and 2011. This young 
woman would be coded as enrolled in school in 2011. If 
a young woman reported grade 7 attainment in 2009 and 
grade 9 attainment in 2012, we assumed that the 2 years 
of additional education were accumulated in 2009 and 
2010. This young woman would be coded as not enrolled 
in school in 2011. Observations with illogical education 
data patterns between 2009 and 2012 (eg, educational 
attainment decreases over time) were coded as missing 
for school enrolment in 2011.
We also explored the potential for confounding and 
effect measure modification by key covariates. We exam-
ined age on 1 January 2011, categorised as ages of compul-
sory school enrolment (ages 11–15 years), older than age 
for compulsory school enrolment but correct age for 
grade (ages 16–17 years), and older than age for compul-
sory school enrolment while also older than expected for 
grade (ages 18–20 years). We also examined indicators 
of household socioeconomic status (SES), measured with 
a composite index of household assets; household size; 
gender of household head; secondary school educational 
attainment of the household head; country of origin 
(South African or Mozambican descent); and pre-2011 
childbearing.
Analysis
We used binomial regression models with an identity link 
to estimate the association between trial participation and 
school enrolment in 2011 and 2015. The 2011 enrolment 
outcome was used to isolate the potential for a sample 
selection effect (ie, Were trial participants more likely 
to be in school than non-participants at the beginning 
of the trial?). We used the 2015 enrolment outcome in a 
restricted cohort of young women who were enrolled in 
school in 2011 to isolate the potential for a Hawthorne 
effect at the end of the trial (ie, Were trial participants 
more likely to remain in school after 4 years than non-par-
ticipants, conditional on being in school at the beginning 
of the trial?).
We conducted unadjusted analyses and analyses 
adjusted for age, SES, gender and education of house-
hold head, household size, country of origin, and 
pre-2011 childbearing. School enrolment decisions were 
likely highly influenced by age both because our cohort 
straddled the age limit for compulsory schooling in South 
Africa and because school dropout generally increases 
with age. Thus, we conducted age-stratified analyses to 
see whether the associations between trial participation 
and school enrolment differed by age category.
Although trial results indicated that school atten-
dance and enrolment outcomes were not significantly 
different between the arms of the trial, the intervention 
was designed to incentivise school attendance.17 For this 
reason, we conducted a sensitivity analysis restricting the 
trial participants to those who were randomly assigned to 
the control group only. We compared results from this 
restricted population with the results from the analysis of 
the full trial population.
results
Overall 3889 young women from the Agincourt HDSS 
were included in our cohort (table 1). The median age 
was 15 years (IQR: 14–16). Young women tended to live in 
large households (mean size: 8.4), and household heads 
were often female (42%) and often lacked high school 
education (86%). The majority of young women were 
of South African descent (60%) and very few (7%) had 
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Table 1 Sociodemographic characteristics of a cohort of 3889 young women between the ages of 11 and 20 years in rural 
Agincourt, South Africa, by participation in the HPTN 068 trial
Total (n=3889) Trial participant* (n=1720) Non-participant (n=2169)
P value†n % n % n %
Age in 2011 <0.0001
  11–12 188 4.8 26 1.5 162 7.5
  13–14 1270 32.7 637 37.0 633 29.2
  15–16 1591 40.9 793 46.1 798 36.8
  17–18 667 17.2 239 13.9 428 19.7
  19–20 173 4.5 25 1.5 148 6.8
SES‡ 0.003
  At or above median 1778 50 853 52.7 925 47.8
  Below median 1778 50 766 47.3 1012 52.3
  Missing 333 101 232
Household size‡ 0.5
  Mean 8.4 8.4 8.5
  SD 4.2 4.0 4.4
  Missing 46 14 32
Gender of household head‡ 0.3
  Female 1590 41.7 691 40.8 899 42.4
  Male 2224 58.3 1004 59.2 1220 57.6
  Missing 75 25 50
Household head educational 
attainment‡ 0.02
  <Grade 12 3062 86.3 1398 87.8 1664 85.1
  Grade 12 or higher 486 13.7 194 12.2 292 14.9
  Missing 341 128 213
Country of origin‡ 0.2
  South Africa 2315 59.6 1046 60.9 1269 58.6
  Mozambique 1570 40.4 673 39.2 897 41.4
  Missing 4 1 3
Childbearing before 2011 <0.0001
  Yes 274 7.1 67 3.9 207 9.5
  No 3615 93.0 1653 96.1 1962 90.5
Intervention arm
  Control 820 50.4
  Intervention 806 49.6
2011 school enrolment <0.0001
  Yes 3508 95.7 1637 99.2 1871 92.9
  No 158 4.3 14 0.9 144 7.2
  Missing 223 69 154
2015 school enrolment <0.0001
  Yes 2465 74.2 1234 19 1231 68.5
  No 856 25.8 290 81 566 31.5
  Missing 568 196 372
*Due to restrictions in the cohort construction to maintain comparable groups with respect to age and education status in 2009, not 
all of the 2533 HPTN 068 participants are represented.
†P values for categorical variables are from Χ2 tests and for continuous variables from t-tests.
‡Measured in 2009.
HPTN, HIV Prevention Trial Network; SES, socioeconomic status. 
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begun childbearing prior to 2011. Just under half of the 
young women (44%) went on to participate in HPTN 068, 
and they tended to be less likely to be on the youngest 
(ages 11–12) or oldest (ages 19–20) end of the age spec-
trum, although the median age of both participants and 
non-participants was 15. Trial participants were also less 
likely to have begun childbearing, slightly more likely to 
live in households headed by high school graduates and 
slightly more likely to live in household with above-me-
dian SES.
In 2011, at the time of HPTN 068 trial start, nearly 
everyone in the cohort was enrolled in school (96%), 
likely due to the age and 2009 enrolment requirements 
placed on the cohort (table 2). However, young women 
who became trial participants were already more likely to 
be enrolled in school (99%) compared with non-partici-
pants (93%) (risk difference (95% CI): 6.3 (5.1 to 7.5)), 
indicating a sample selection effect likely occurred as a 
consequence of the school enrolment eligibility criterion. 
Although the overall association attenuated after covariate 
adjustment (adjusted risk difference (aRD) (95% CI): 
2.9 (−0.7 to 6.5)), strong associations were observed in 
the age group of 18–20 years old (aRD (95% CI): 19.5 
(5.6 to 33.3)), compared with the younger two age groups 
(aRD11–15 (95% CI): 0.4 (−5.2 to 5.9); aRD16–17 (95% CI): 
6.3 (0.5 to 12.2)).
At the end of the trial in 2015, the difference in school 
enrolment between trial participants (81%) and non-par-
ticipants (69%) grew, with an adjusted overall risk differ-
ence of 6.8 (95% CI 3.4 to 10.2). To investigate whether 
any differences in school enrolment could be attributed 
to a Hawthorne effect, we restricted the cohort to those 
enrolled in school in 2011 and examined differences in 
2015. Under this restriction, young women enrolled in 
the trial were still more likely to remain in school in 2015 
(82%), compared with those who did not (74%), with an 
aRD of 4.9 (95% CI 1.5 to 8.3)). Again, the association 
was weakest among those 11–15 years old (aRD (95% CI): 
1.8 (−1.3 to 5.0)) and strongest among those 18–20 years 
old (aRD (95% CI): 22.8 (7.3 to 38.2)).
Results were largely unchanged when we restricted 
the trial participant population to those assigned to the 
control group only (table 3). Although CIs widened due 
to reduced sample size with some newly spanning the 
null, the magnitudes of the risk difference point esti-
mates were largely unchanged from those in the primary 
analysis.
dIsCussIOn
HPTN 068 found that cash transfers conditional on 
school enrolment did not influence HIV acquisition 
among young women in a rural South African setting. 
Due to unexpectedly high levels of school enrolment in 
both arms, the ability to explore schooling as a mecha-
nism through which cash transfers could influence HIV 
acquisition was limited. Here, we found evidence to 
suggest that both Hawthorne effects and sample selection 
effects could threaten the external validity of these find-
ings. Overall, trial participants were more likely to remain 
in school until graduation than non-participants. Differ-
ences in school enrolment status were already apparent at 
the beginning of the study, suggesting that the trial selec-
tion criteria likely pulled in young women with better 
school enrolment behaviours than those who were not 
enrolled as trial participants (sample selection effect). 
Differences in school enrolment grew larger as the trial 
progressed, and importantly remained strong even after 
restricting to those enrolled in school in 2011 when the 
trial started, suggesting the changes in enrolment status 
occurred during the trial itself (Hawthorne effect). Both 
sample selection and Hawthorne effects may have dimin-
ished the differences in school enrolment between study 
arms and is one plausible explanation for the overall null 
study effect. The HPTN 068 trial was designed to activate 
the HIV prevention effects of education by incentivising 
school attendance and retention in the intervention 
arm. With high levels of school attendance and retention 
across both arms of the trial, the ability to detect a trial 
effect was likely weakened.
Our findings that trial participation influenced school 
enrolment behaviour could plausibly be explained by 
several characteristics of the HPTN 068 study design and 
protocol. First, all participants were aware of the objective 
of the study: to retain young women in school to prevent 
HIV. This information could result in school enrolment 
behaviour change to align with perceived expectations of 
study staff or because young women were motivated to 
prevent HIV. Second, compared with non-participants, 
trial participants were exposed to different networks likely 
to be supportive of school enrolment. Adult fieldworkers 
showed interest in the schooling of participants with yearly 
in-person data collection and monthly in-school data 
collection. Data were collected in ‘camps’ wherein trial 
participants were transported to study offices annually 
for a half-day of surveys and blood tests, and entertaining 
activities during wait periods (eg, fingernail painting, 
photograph taking, magazine reading). This protocol 
could have fostered a cohesive group environment 
among trial participants resulting in positive peer pres-
sure to maintain school enrolment. There is a growing 
body of evidence that interventions providing a safe space 
with adult mentorship and peer support can have positive 
outcomes for young women in sub-Saharan Africa,24–26 a 
pathway that may have been activated with trial participa-
tion. Finally, trial participation provided access to certain 
health and social services that may have otherwise been 
inaccessible, including annual HIV and herpes simplex 
virus type 2  (HSV-2) testing and counselling, linkage to 
care for those who tested positive, and linkage to social 
work services for young women who reported experiences 
of sexual abuse. These services may have enabled young 
women who would have otherwise struggled with serious 
physical and mental health outcomes to remain in school.
Associations between trial participation and school 
enrolment were strongest in older age groups. The small 
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Table 2 The relationship between HPTN 068 trial participation and school enrolment in 2011 and 2015, stratified by age, in 
the full cohort and the cohort restricted to those enrolled in school in 2011
Enrolment n Per cent enrolled RD (95% CI) aRD* (95% CI)
2011: full cohort
All ages
  Trial participant 1637 1651 99.2 (98.7, 99.6) 6.3 (5.1 to 7.5) 2.9 (−0.7 to 6.5)
  Non-trial participant 1871 2015 92.9 (91.7, 94.0) 1 1
Ages 11–15
  Trial participant 1036 1038 99.8 (99.5, 1.00) 0.6 (0.0 to 1.2) 0.4 (−5.2 to 5.9)
  Non-trial participant 1115 1124 99.2 (98.6, 99.7) 1 1
Ages 16–17
  Trial participant 532 539 98.7 (97.8, 99.7) 6.9 (4.6 to 9.2) 6.3 (0.5 to 12.2)
  Non-trial participant 593 646 91.8 (89.7, 93.9) 1 1
Ages 18–20
  Trial participant 69 74 93.2 (87.5, 99.0) 26.7 (18.5 to 34.9) 19.5 (5.6 to 33.3)
  Non-trial participant 163 245 66.5 (60.6, 72.4) 1 1
2015: full cohort
All ages
  Trial participant 1234 1524 81.0 (79.0, 83.0) 12.5 (9.6 to 15.4) 6.8 (3.4 to 10.2)
  Non-trial participant 1231 1797 68.5 (66.4, 70.7) 1 1
Ages 11–15
  Trial participant 837 952 87.9 (85.9, 90.0) 3.8 (0.1 to 6.9) 1.9 (− 1.3 to 5.0)
  Non-trial participant 833 990 84.1 (81.9, 86.5) 1 1
Ages 16–17
  Trial participant 361 503 71.8 (67.9, 75.8) 12.5 (6.9 to 18.1) 12.7 (6.7 to 18.7)
  Non-trial participant 346 584 59.3 (55.4, 63.4) 1 1
Ages 18–20
  Trial participant 36 69 52.2 (41.6, 65.4) 28.9 (15.8 to 41.9) 29.7 (16.1 to 43.3)
  Non-trial participant 52 223 23.3 (18.4, 29.6) 1 1
2015: restricted cohort†
All ages
  Trial participant 1234 1510 81.7 (79.8, 83.7) 7.3 (4.5 to 10.2) 4.9 (1.5 to 8.3)
  Non-trial participant 1231 1655 74.4 (72.3, 76.5) 1 1
Ages 11–15
  Trial participant 837 950 88.1 (86.1, 90.2) 3.2 (0.2 to 6.3) 1.8 (−1.3 to 5.0)
  Non-trial participant 833 982 84.8 (82.6, 87.1) 1 1
Ages 16–17
  Trial participant 361 496 72.8 (69.0, 76.8) 7.6 (1.9 to 13.3) 7.9 (1.9 to 14.0)
  Non-trial participant 346 531 65.2 (61.2, 69.3) 1 1
Ages 18–20
  Trial participant 36 64 56.3 (45.3, 69.8) 19.6 (5.1 to 34.1) 22.8 (7.3 to 38.2)
  Non-trial participant 52 142 36.6 (29.5, 45.5) 1 1
*Adjusted for socioeconomic status (coded dichotomously at median household asset index score), country of origin (South African vs 
Mozambican), educational attainment of household head (coded dichotomously at grade 12 attainment), gender of household head (male vs 
female), household size (coded linearly) and pre-2011 childbearing (yes vs no). Models that are not age-stratified are also adjusted for age 
coded in 2-year categories.
†Restricted to all young women who were enrolled in school in 2011.
aRD, adjusted risk difference; HPTN, HIV Prevention Trial Network; RD, risk difference.
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Table 3 Sensitivity analysis comparing differences in school enrolment between HPTN 068 trial participants in the control arm 
only and non-trial participants
Enrolment n Per cent enrolled RD (95% CI) aRD* (95% CI)
2011: full cohort
All ages
  Trial participant (control) 862 872 98.9 (98.2, 99.6) 6.0 (4.7 to 7.3) 3.2 (−1.4 to 7.7)
  Non-trial participant 1871 2015 92.9 (91.7, 94.0) 1 1
Ages 11–15
  Trial participant (control) 543 544 99.8 (99.5, 1.00) 0.6 (0.0 to 1.3) 0.4 (−7.3 to 8.0)
  Non-trial participant 1115 1124 99.2 (98.6, 99.7 1 1
Ages 16–17
  Trial participant (control) 280 285 98.3 (96.7, 99.8) 6.5 (3.8 to 9.1) 5.7 (−0.9 to 12.3)
  Non-trial participant 593 646 91.8 (89.7, 93.9) 1 1
Ages 18–20
  Trial participant (control) 39 43 90.7 (82.0, 99.4) 24.2 (13.7 to 34.7) 17.7 (2.6 to 32.8)
  Non-trial participant 163 245 66.5 (60.6, 72.4) 1 1
2015: full cohort
All ages
  Trial participant (control) 653 813 80.3 (77.6, 83.1) 11.8 (8.3 to 15.3) 6.9 (3.6 to 10.3)
  Non-trial participant 1231 1797 68.5 (66.4, 70.7) 1 1
Ages 11–15
  Trial participant (control) 448 504 88.9 (86.2, 91.6) 4.8 (1.2 to 8.3) 2.4 (−1.3 to 6.1)
  Non-trial participant 833 990 84.1 (81.9, 86.5) 1 1
Ages 16–17
  Trial participant (control) 186 269 69.1 (63.6, 74.7) 9.9 (3.1 to 16.7) 9.7 (2.6 to 16.8)
  Non-trial participant 346 584 59.3 (55.4, 63.4) 1 1
Ages 18–20
  Trial participant (control) 19 40 47.5 (32.0, 63.0) 24.2 (7.7 to 40.6) 21.5 (4.9 to 38.1)
  Non-trial participant 52 223 23.3 (18.4, 29.6) 1 1
2015: restricted cohort†
All ages
  Trial participant (control) 653 803 81.3 (78.6, 84.0) 6.9 (3.5 to 10.4) 4.5 (1.3 to 7.6)
  Non-trial participant 1231 1655 74.4 (72.3, 76.5) 1 1
Ages 11–15
  Trial participant (control) 448 503 89.1 (86.3, 91.8) 4.2 (0.7 to 7.8) 2.5 (−1.2 to 6.2)
  Non-trial participant 833 982 84.8 (82.6, 87.1) 1 1
Ages 16–17
  Trial participant (control) 186 264 70.5 (65.0, 76.0) 5.3 (−1.5 to 12.1) 5.2 (−2.0 to 12.3)
  Non-trial participant 346 531 65.2 (61.2, 69.3) 1 1
Ages 18–20
  Trial participant (control) 19 36 52.8 (36.5, 69.1) 16.2 (−2.0 to 34.3) 13.8 (−5.7 to 33.4)
  Non-trial participant 52 142 36.6 (29.5, 45.5) 1 1
School enrolment outcome was analysed in 2011 and 2015 and the analysis was stratified by age, in the full cohort and the cohort restricted 
to those enrolled in school in 2011.
*Adjusted for socioeconomic status (coded dichotomously at median household asset index score), country of origin (South African vs 
Mozambican), educational attainment of household head (coded dichotomously at grade 12 attainment), gender of household head (male vs 
female), household size (coded linearly) and pre-2011 childbearing (yes vs no). Models that are not age-stratified are also adjusted for age 
coded in 2-year categories.
†Restricted to all young women who were enrolled in school in 2011.
aRD, adjusted risk difference; HPTN, HIV Prevention Trial Network; RD, risk difference.
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differences observed in the youngest age group are under-
standable as they were under the age limit of compulsory 
education with requirements to remain in school regard-
less of trial influence. For the oldest age group, trial selec-
tion criteria for lower grade levels meant they were older 
than expected for their grade, and suggested a history 
of grade repetition or temporary dropout. That the trial 
protocol may have contributed to keeping older teens in 
school is significant as the transition to adulthood carries 
extremely high HIV risk.23
This study was fairly unusual in that data were available 
on key study outcomes for the underlying population 
from which study participants were drawn. The Agincourt 
HDSS routinely collects school enrolment data on all resi-
dents in the study area, and we were able to leverage those 
data to assess differences between trial participants and 
non-participants. The majority of epidemiological studies 
do not have the benefit of complete background data on 
the target population, and, as such, sample selection and 
Hawthorne effects are rarely empirically assessed.5 10 12 14 
However, when Hawthorne effects are assessed, the direc-
tion of the relationship between research participation 
and healthy outcomes tends to be positive, in line with 
our findings of improved school enrolment outcomes.
It is important to note that data on HIV incidence, 
the primary endpoint of HPTN 068, were not available 
for the underlying target population. We speculate that 
the improved schooling trajectories we observed in 
trial participants likely resulted in reduced risk of HIV 
acquisition.17 Continued schooling is strongly associated 
with HIV prevention and reduced sexual risk outcomes 
in young women in sub-Saharan Africa,18 27 28 and we 
observed lower HIV incidence (1.8%) than expected 
among trial participants (3%). However, we cannot say 
with certainty that the association between trial participa-
tion and school enrolment extended to HIV protection.
The potential for uncontrolled confounding requires 
that our results be interpreted cautiously. The differences 
we attribute to the Hawthorne effect were estimated in an 
observational data set. Initial screens for trial eligibility 
were performed based on age data maintained by the 
Agincourt HDSS, and 82% of the eligible young women 
approached went on to enrol in the study, a fairly high 
response rate.17 Still, it is plausible that those who refused 
participation were different from those who consented 
in ways that were also related to future school enrol-
ment trajectories. Although we controlled for key socio-
demographic characteristics that we theorised could be 
related to both trial participation and school enrolment, 
the possibility for bias from unmeasured confounding 
remains.
We offer three key conclusions from this study. First, 
epidemiologists should give greater weight at the plan-
ning, analysis and dissemination stages to identifying how 
sample selection and Hawthorne effects can be mini-
mised, assessed and discussed. Prioritising research with 
well-defined target populations in areas with ongoing 
background data collection (eg, HDSS centres) would 
improve researchers’ abilities to empirically assess the 
external validity of their findings. Second, the sample 
selection effect we observed highlights how school-based 
samples can differ in important ways from non-school-
based samples in terms of underlying risk. Interventions 
focused on school-going adolescents may not reach those 
most in need of prevention, an anticipated issue that was 
ultimately difficult to avoid given the HPTN 068 design. 
Third, the Hawthorne-specific findings suggest that 
aspects of the HPTN 068 protocol could potentially be 
adapted for school retention interventions to prevent 
HIV. If the relationship we observed is causal, the trial 
protocol increased school enrolment at a magnitude 
similar to targeted cash transfer interventions and other 
fairly resource-intensive school retention interventions in 
sub-Saharan Africa,21 29–31 despite the actual contact with 
the young women being limited to annual visits. Future 
work should examine key elements of the study protocol—
adult mentorship, peer support, school attendance moni-
toring, messaging around the link between school and 
HIV, routine HIV/sexually transmitted infection testing 
and linkage to care—to better understand their relation-
ship with school retention and HIV acquisition.
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